T‐cell modulation by cyclophosphamide for tumour therapy

Hughes, Ellyn, Scurr, Martin ORCID: https://orcid.org/0000-0002-4120-0688, Campbell, Emma, Jones, Emma, Godkin, Andrew ORCID: https://orcid.org/0000-0002-1910-7567 and Gallimore, Awen ORCID: https://orcid.org/0000-0001-6675-7004 2018. T‐cell modulation by cyclophosphamide for tumour therapy. Immunology 154 (1) , pp. 62-68. 10.1111/imm.12913

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (194kB) | Preview

Abstract

The power of T cells for cancer treatment has been demonstrated by the success of co‐inhibitory receptor blockade and adoptive T‐cell immunotherapies. These treatments are highly successful for certain cancers, but are often personalized, expensive and associated with harmful side effects. Other T‐cell‐modulating drugs may provide additional means of improving immune responses to tumours without these disadvantages. Conventional chemotherapeutic drugs are traditionally used to target cancers directly; however, it is clear that some also have significant immune‐modulating effects that can be harnessed to target tumours. Cyclophosphamide is one such drug; used at lower doses than in mainstream chemotherapy, it can perturb immune homeostasis, tipping the balance towards generation of anti‐tumour T‐cell responses and control of cancer growth. This review discusses its growing reputation as an immune‐modulator whose multiple effects synergize with the microbiota to tip the balance towards tumour immunity offering widespread benefits as a safe, and relatively inexpensive component of cancer immunotherapy.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	0019-2805
Funders:	Cancer Research UK
Date of First Compliant Deposit:	14 March 2018
Date of Acceptance:	14 February 2018
Last Modified:	05 Jan 2024 06:44
URI:	https://orca.cardiff.ac.uk/id/eprint/109873

Citation Data

Cited 34 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item